Pieter A. Meyer - Publications

Immunological and Clinical Impacts of Targeted Intraoperative Radiotherapy in Breast Cancer: A Narrative Review.

Journal: Cureus

Published: October 10, 2025

Sodium, Potassium-Adenosine Triphosphatase as a Potential Target of the Anti-Tuberculosis Agents, Clofazimine and Bedaquiline.

Journal: International journal of molecular sciences

Published: September 16, 2024

Radiologic Specific Growth Rate of Ameloblastomas: A Clinicopathological Correlation.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: July 03, 2024

SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination.

Journal: Journal of clinical pathology

Published: June 21, 2024

The Effect of the COVID-19 Pandemic on Suicide Trends in Pretoria, South Africa.

Journal: The American journal of forensic medicine and pathology

Published: June 04, 2024

Comparison of SARS-CoV-2 molecular results from the first two COVID-19 waves in Gauteng.

Journal: Southern African journal of infectious diseases

Published: May 09, 2024

A radiologic-pathologic study of the histopathologic variants of ameloblastomas and their proliferation indices.

Journal: Oral surgery, oral medicine, oral pathology and oral radiology

Published: November 07, 2023

Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma.

Journal: Translational oncology

Published: October 01, 2023

Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro Study.

Journal: Molecules (Basel, Switzerland)

Published: November 23, 2022

Dolutegravir potentiates platelet activation by a calcium-dependent, ionophore-like mechanism.

Journal: Journal of immunotoxicology

Published: November 17, 2022

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3.

Journal: Frontiers in oncology

Published: November 13, 2022

Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.

Journal: The Journal of infection

Published: June 07, 2022